Norway plans to use the three vaccines developed by Moderna, AstraZeneca, Pfizer and BioNTech in its first push to inoculate its population against COVID-19, the country’s health minister said on Friday.
In the first quarter of 2021, Oslo expects to receive a total of 2.5 million doses, covering 1.25 million people, pending approval of the vaccines from European regulators. Norway’s population is 5.4 million.
Non-EU Norway will get access to some of the vaccines obtained by the European Union thanks to Sweden, an EU member that will buy more than it needs and sell them to Norway, right after New Year.
“By Easter, we could be in a completely different situation than today,” Health Minister Bente Hoeie told a news conference. The timeline in Norway is speedier than earlier announced. In October, Prime Minister Erna Solberg had said she expected vaccinations to start in the first half of next year.
Countries worldwide are trying to vaccinate as quickly as possible, as vaccines supplies become available and decide which population groups should get it first. Britain on Wednesday became the first nation in the Western world to approve a COVID-19 vaccine, the one developed by Pfizer and BioNTech.
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
Please Email the Editor